Paediatric powered endonasal dacryocystorhinostomy

Dania Al-Nuaimi1, Clare Inkster, Christopher Lobo

  • 1Department of Ophthalmology, Royal Bolton Hospital NHS Foundation Trust, Minerva Road, Farnworth, Bolton, UK. dania1979@doctors.org.uk

Insights

Endoscopic endonasal dacryocystorhinostomy (DCR) effectively treats persistent nasolacrimal duct obstruction (NLDO) in children. This minimally invasive procedure offers high success rates, improving symptoms in most pediatric patients.

Area of Science:

  • Ophthalmology
  • Otorhinolaryngology
  • Pediatric Surgery

Background:

  • Persistent nasolacrimal duct obstruction (NLDO) is a common condition in children requiring surgical intervention.
  • Dacryocystorhinostomy (DCR) is the standard surgical treatment for NLDO.
  • Endoscopic endonasal DCR offers a minimally invasive alternative to external DCR.

Purpose of the Study:

  • To evaluate the outcomes of pediatric patients undergoing endonasal endoscopic DCR.
  • To assess the safety and efficacy of this procedure in a district general hospital setting.
  • To identify factors influencing treatment success.

Main Methods:

  • Retrospective review of pediatric patients (ages 2-14) undergoing endonasal endoscopic DCR.
  • Data collected from October 2001 to December 2008.
  • Main outcome measure was symptom resolution (epiphora, discharge).

Main Results:

  • Sixteen children (17 eyes) were analyzed.
  • 82% presented with epiphora; 3 had Down syndrome.
  • No operative complications were reported.
  • 12-month follow-up showed symptom improvement in all but one case.
  • 60% achieved complete symptom resolution; others were minimally symptomatic.
  • Residual symptoms were noted in two patients with Down syndrome.

Conclusions:

  • Endonasal endoscopic DCR is a safe and effective treatment for pediatric NLDO.
  • Success rates are higher in children without craniofacial abnormalities.
  • Multidisciplinary care involving Oculoplastic and ENT surgeons optimizes patient outcomes.